VIADERMA CLEAR ACNE TREATMENT- salicylic acid solution

Viaderma Clear Acne Treatment by

Drug Labeling and Warnings

Viaderma Clear Acne Treatment by is a Otc medication manufactured, distributed, or labeled by VIADERMA DISTRIBUTION INC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredient

Salicylic Acid 2%

Purpose

Acne Treatment

Uses

• For the treatment of acne.
• Clears up most acne blemishes, acne pimples, blackheads and allows skin to heal.
• Penetrates pores to eliminate most acne conditions.
• Hepls prevent new acne blemishes, pimples and blackheads from forming.

Warnings

For external use only.

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions 

• Clean the skin thoroughly before applying this product
• Cover the entire affected area with a thin layer one to three times daily
• Because excessive drying of the skin may

Other information

• store between 68-77°F (20-25°C)
• Avoid extreme temperatures (freezing or heating)

Inactive ingredients

Acetic acid, caprylic/capric triglyceride, cholecalciferol, dimethyl sulfoxide, dipropylene glycol, gluconolactone, glycerin, histidine, hydroxyethyl-cellulose, magnesium stearate, sodium hydroxide, sorbic acid, stearic acid, tetrahexyldecyl ascorbate, tocopherol, water.

Package Labeling:

INGREDIENTS AND APPEARANCE

VIADERMA CLEAR ACNE TREATMENT 
salicylic acid solution

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71262-017
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
ACETIC ACID (UNII: Q40Q9N063P)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
CHOLECALCIFEROL (UNII: 1C6V77QF41)
DIMETHYL SULFOXIDE (UNII: YOW8V9698H)
DIPROPYLENE GLYCOL (UNII: E107L85C40)
GLUCONOLACTONE (UNII: WQ29KQ9POT)
GLYCERIN (UNII: PDC6A3C0OX)
HISTIDINE (UNII: 4QD397987E)
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)
MAGNESIUM STEARATE (UNII: 70097M6I30)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SORBIC ACID (UNII: X045WJ989B)
STEARIC ACID (UNII: 4ELV7Z65AP)
TETRAHEXYLDECYL ASCORBATE (UNII: 9LBV3F07AZ)
TOCOPHEROL (UNII: R0ZB2556P8)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71262-017-15	1 in 1 CARTON	12/05/2025
1		15 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	12/05/2025

Labeler - VIADERMA DISTRIBUTION INC (081113521)

Registrant - VIADERMA DISTRIBUTION INC (081113521)